Trial Profile
IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2014
Price :
$35
*
At a glance
- Drugs Brinzolamide (Primary) ; Travoprost/timolol
- Indications Glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 19 Jun 2014 New trial record